After a months-long halt on production, Emergent is back up and running in Baltimore
It’s been a long time since Emergent BioSolutions has been able to produce Covid-19 vaccines at its Baltimore Bayview plant, but the FDA has given …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
